German China

Additive Manufacturing
3D Printing in Labs: From Personalized Drugs to Bioprinted Organs

From Ahlam Rais 5 min Reading Time

Related Vendors

Laboratories are increasingly making use of the 3D printing technology to develop 3D printed drugs, lab-on-a-chip systems and even bioprint tissues and organs. With such transformative changes taking place, 3D printing is redefining what is possible in medicine and R&D.

3D bioprinting functions on the same principles of AM but the only difference is that instead of utilizing materials for deposition, it can use any of the following: live cells, hydrogels, extracellular matrices and biomaterials to produce complex tissues or organs. (Source: ©  Jeffrey116 - stock.adobe.com)
3D bioprinting functions on the same principles of AM but the only difference is that instead of utilizing materials for deposition, it can use any of the following: live cells, hydrogels, extracellular matrices and biomaterials to produce complex tissues or organs.
(Source: © Jeffrey116 - stock.adobe.com)

The 3D printing or Additive Manufacturing (AM) technology is gaining momentum across the globe. Used to develop complex, sturdy, lightweight parts quickly as compared to the more traditional method of machining, the 3D printing technology makes use of a layer-by-layer approach to produce the final product. Be it the aerospace, automotive or energy sector, the 3D printing technology is revolutionizing sectors and impressing industry leaders with its numerous advantages. According to a report by market research firm Vantage Market Research, the 3D printing market is expected to grow from 19.33 billion dollars in 2024 to 210.5 billion dollars by 2035, expanding at a robust CAGR of 24.25 % between 2025 and 2035. This shows great demand for this technology.

In fact, even laboratories are actively using and exploring this innovative solution for 3D printing drugs, rapid prototyping of lab-on-a-chip systems, and bioprinting tissues & organs.